Table 1.
Baseline characteristics of patients
| Characteristics | UC-MSCS (N = 45) | Placebo (N = 46) | p-value |
|---|---|---|---|
| Age (years) | 50.00 ± 9.38 | 50.45 ± 8.03 | 0.8068 |
| Gender (male) (n (%)) | 28 (62.22%) | 30 (68.18%) | 0.5552 |
| BMI (kg/m2) | 28.69 ± 3.35 | 28.13 ± 3.04 | 0.4158 |
| Duration of diabetes (years) | 11.44 ± 4.78 | 11.70 ± 3.96 | 0.7808 |
| Insulin requirement (U/day) | 57.36 + 18.90 | 56.41 + 12.54 | 0.7819 |
| Insulin requirement (U/kg/day) | 0.72 ± 0.20 | 0.71 ± 0.15 | 0.6992 |
| Fasting plasma glucose (mmol/L) | 8.71 ± 2.16 | 8.58 ± 1.93 | 0.7737 |
| Glycated hemoglobin A1c (%) | 9.02 ± 1.27 | 8.89 ± 1.11 | 0.6173 |
| Fasting C-peptide (ng/mL) | 2.01 ± 0.70 | 1.93 ± 0.65 | 0.5905 |
| GIR (mg/min/kg) | 3.12 ± 1.46 | 3.26 ± 1.16 | 0.6177 |
Data are shown as mean ± SD or n (%). GIR, Glucose infusion rate